CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 67 filers reported holding CTI BIOPHARMA CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $8,000 | -57.9% | 15,044 | 0.0% | 0.00% | – |
| Q4 2015 | $19,000 | +11.8% | 15,044 | +29.6% | 0.00% | – |
| Q3 2015 | $17,000 | -26.1% | 11,611 | 0.0% | 0.00% | – |
| Q2 2015 | $23,000 | +9.5% | 11,611 | 0.0% | 0.00% | – |
| Q1 2015 | $21,000 | -16.0% | 11,611 | +11.6% | 0.00% | – |
| Q4 2014 | $25,000 | -3.8% | 10,402 | -3.7% | 0.00% | – |
| Q3 2014 | $26,000 | -13.3% | 10,800 | 0.0% | 0.00% | – |
| Q2 2014 | $30,000 | – | 10,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 10,698,618 | $13,159,000 | 15.42% |
| BVF INC/IL | 43,795,613 | $53,869,000 | 9.18% |
| DAFNA Capital Management LLC | 3,195,381 | $3,930,000 | 3.50% |
| Sio Capital Management, LLC | 5,292,262 | $6,509,000 | 2.88% |
| NEXTHERA CAPITAL LP | 656,000 | $807,000 | 1.14% |
| Lombard Odier Asset Management (USA) Corp | 1,357,456 | $1,670,000 | 0.16% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,236,832 | $2,751,000 | 0.11% |
| Consonance Capital Management LP | 510,000 | $635,000 | 0.08% |
| Candriam S.C.A. | 1,515,000 | $1,863,000 | 0.05% |
| SABBY MANAGEMENT, LLC | 575,669 | $708,000 | 0.04% |